A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease
Broad Institute · Harvard University · +15 more institutions
Abstract
Abstract Identification of individuals at highest risk of coronary artery disease (CAD)—ideally before onset—remains an important public health need. Prior studies have developed genome-wide polygenic scores to enable risk stratification, reflecting the substantial inherited component to CAD risk. Here we develop a new and significantly improved polygenic score for CAD, termed GPS Mult , that incorporates genome-wide association data across five ancestries for CAD (>269,000 cases and >1,178,000 controls) and ten CAD risk factors. GPS Mult strongly associated with prevalent CAD (odds ratio per standard deviation 2.14, 95% confidence interval 2.10–2.19, P < 0.001) in UK Biobank participants of European…
Citation impact
- FWCI
- 72.75
- Percentile
- 100%
- References
- 116
Authors
20- APAniruddh P. PatelCorresponding
Broad Institute, Harvard University, Massachusetts General Hospital
- MWMinxian Wang
Chinese Academy of Sciences, Beijing Institute of Genomics
- YRYunfeng Ruan
Broad Institute, Massachusetts General Hospital
- SKSatoshi Koyama
Broad Institute, VA Boston Healthcare System, Massachusetts General Hospital
- SLShoa L. Clarke
Palo Alto University, VA Palo Alto Health Care System, Stanford University
Topics & keywords
- Odds ratio
- Confidence interval
- Coronary artery disease
- Medicine
- Framingham Risk Score
- Genome-wide association study
- Hazard ratio
- Polygenic risk score
Funding
- UDU.S. Department of Veterans AffairsAwards: I01-BX004821, 01BX003362
- AHAmerican Heart AssociationAwards: 17IFUNP3384001, 18SFRN34110082, 862032, MAESTRIA 965286
- BSBristol-Myers Squibb
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- MGMassachusetts General Hospital
- OOOffice of Research and Development
- APAlnylam Pharmaceuticals
- HCHarvard Catalyst
- BIBroad Institute
- SCSarnoff Cardiovascular Research Foundation
- BCBarts CharityAward: 845/1796
- MTMaze Therapeutics
- NINational Institute for Health and Care ResearchAwards: BRC-1215-20014, NIHR203312
- BHBritish Heart FoundationAwards: RG/18/13/33946, RE/18/1/34212, CH/12/2/29428
- KCKing's College London
- ECEuropean CommissionAwards: MAESTRIA 965286, 862032, 965286
- PHPublic Health England
- NNNovo Nordisk
- BHBarts Health NHS Trust
- MRMedical Research CouncilAwards: MR/X009920/1, HDR-23013, MR/X009777/1, NIHR203312, HDR-23007, M009017, MR/X009920/1, BRC-1215-20014, MR/S027297/1
- NCNIHR Cambridge Biomedical Research CentreAwards: BRC-1215-20014 and NIHR203312, BRC-1215-20014, NIHR203312
- NHNational Heart, Lung, and Blood InstituteAwards: 1RO1HL092577, 1R01HL157635, R01HL1427, 1K08HL161448, R01HL148565, 1K08HL153937, R01HL148050
- NHNational Human Genome Research InstituteAwards: 1U01HG011719, 965286, 1R01HL157635, 1K08HG010155, 18SFRN34110082